RESOURCES OPEN CLINICAL TRIALS IN SONOMA COUNTY 2022 This list of open, FDA-approved clinical trials in Sonoma County is intended to increase awareness of local medical research and to benefit physicians who may wish to refer patients. Organized by condition, each listing includes basic information about who may be eligible and what medical provider is conducting the study. As this list is subject to frequent changes, please contact the individual research groups or your primary care provider for the latest information (contacts listed on page 78). Source: www.clinicaltrials.gov (Dec. 1, 2021) ALZHEIMER’S / DEMENTIA NCT05026866: A Donanemab (LY3002813) Prevention Study in Participants with Preclinical Alzheimer’s Disease (TRAILBLAZER-ALZ 3); Phase III Age: 55 years to 80 years Location: Providence Medical Foundation, Santa Rosa, Calif. and more (national)
CANCER Anal cancer NCT04444921: EA2176: Trial of Carboplatin and Pacliitaxel +/- Nivolumab in Metastatic Anal Cancer Patients; Phase III Age: 18 years and older Location: Kaiser Permanente, Santa Rosa, Calif.; Rohnert Park Cancer Center, Rohnert Park, Calif. and more (national)
Bladder cancer NCT03288545: A Study of Enfortumab Vedotin Alone or with Other Therapies for Treatment of Urothelial Cancer; Phase I, Phase II Age: 18 years and older Location: Providence Medical Foundation, Santa Rosa, Calif. and more (international)
72
SONOMA HEALTH
NCT04637594: Trying to Find the Correct Length of Treatment with Immune Checkpoint Therapy; Phase III Age: 18 years and older Location: Kaiser Permanente, Santa Rosa, Calif.; Rohnert Park Cancer Center, Rohnert Park, Calif. and more (national)
Blood cancers NCT04071457: S1803, Lenalidomide +/- Daratumumab/ rHuPh20 as Post-ASCT Maintenance for Multiple Myeloma w/MRD to Direct Therapy Duration; Phase III Age: 18 years to 75 years Location: Kaiser Permanente, Santa Rosa, Calif.; Rohnert Park Cancer Center, Rohnert Park, Calif. and more (national) NCT03150693: Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults with Newly Diagnosed B Acute Lymphoblastic Leukemia; Phase III Age: 18 years to 39 years Location: Kaiser Permanente, Santa Rosa, Calif.; Rohnert Park Cancer Center, Rohnert Park, Calif. and more (North America)
NCT03893682: A Study of CG806 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma or Non-Hodgkin’s Lymphomas; Phase I Age: 18 years and older Location: Providence Medical Foundation, Santa Rosa, Calif. and more (national) NCT03269669: Obinutuzumab with or without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients with Relapsed or Refractory Grade I-IIIa Follicular Lymphoma; Phase II Age: 18 years and older Location: Kaiser Permanente, Santa Rosa, Calif.; Sutter Pacific Medical Foundation, Santa Rosa, Calif. and more (national) NCT01896999: Brentuximab Vedotin and Nivolumab with or without Ipilimumab in Treating Patients with Relapsed or Refractory Hodgkin Lymphoma; Phase I, Phase II Age: 12 years and older Location: Kaiser Permanente, Santa Rosa, Calif.; Rohnert Park Cancer Center, Rohnert Park, Calif. and more (national)
Brain and spinal cancers NCT02179086: Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients with Newly Diagnosed Glioblastoma; Phase II Age: 18 years and older Location: Rohnert Park Cancer Center, Rohnert Park, Calif. and more (North America) NCT03180268: Observation or Radiation Therapy in Treating Patients with Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery; Phase III Age: 18 years and older Location: Rohnert Park Cancer Center, Rohnert Park, Calif. and more (international) NCT02523014: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with Progressive Meningiomas; Phase II Age: 18 years and older Phases: Phase 2 Location: Kaiser Permanente, Santa Rosa, Calif.; Sutter Pacific Medical Foundation, Santa Rosa, Calif. and more (national) NCT03550391: Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases; Phase III Age: 18 years and older Location: Rohnert Park Cancer Center, Rohnert Park, Calif. and more (North America)
